Transmedics Group Inc
(TMDX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,547 | -23,756 | N/A | N/A | N/A |
| Depreciation Amortization | 1,222 | 769 | N/A | N/A | N/A |
| Accounts receivable | -3,166 | -2,513 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,443 | 164 | N/A | N/A | N/A |
| Other Working Capital | -1,626 | -4,327 | N/A | N/A | N/A |
| Other Operating Activity | 1,388 | 3,679 | 0 | 0 | 0 |
| Operating Cash Flow | $-32,286 | $-25,984 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -82,371 | N/A | N/A | N/A | N/A |
| PPE Investments | -165 | -418 | N/A | N/A | N/A |
| Sale Of Investment | 22,035 | 12,725 | N/A | N/A | N/A |
| Investing Cash Flow | $-60,501 | $12,307 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 33,436 | N/A | N/A | N/A |
| Debt Repayment | N/A | -9,076 | N/A | N/A | N/A |
| Common Stock Issued | 97,569 | 46 | N/A | N/A | N/A |
| Other Financing Activity | -4,846 | -2,342 | 0 | 0 | 0 |
| Financing Cash Flow | $92,723 | $22,064 | $N/A | $N/A | $N/A |
| Exchange Rate Effect | -85 | -82 | N/A | N/A | N/A |
| Beginning Cash Position | 20,741 | 12,436 | N/A | N/A | N/A |
| End Cash Position | 20,592 | 20,741 | N/A | N/A | N/A |
| Net Cash Flow | $-149 | $8,305 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,286 | -25,984 | N/A | N/A | N/A |
| Capital Expenditure | -165 | -418 | N/A | N/A | N/A |
| Free Cash Flow | -32,451 | -26,402 | 0 | 0 | 0 |